Brief: Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights And Select Anticipated Milestones
30/03/2023 22:24
March 30 (Reuters) - Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA REPORTS FULL YEAR 2022 FINANCIAL RESULTS,
BUSINESS HIGHLIGHTS AND SELECT ANTICIPATED MILESTONES
* SUTRO BIOPHARMA INC - PROJECTED CASH RUNWAY INTO SECOND
HALF OF
2024
* SUTRO BIOPHARMA INC - PLANS TO INITIATE A PHASE 2/3
REGISTRATION-DIRECTED STUDY OF LUVELTA FOR PATIENTS WITH
PLATINUM RESISTANT OVARIAN CANCER IN Q2
Source text for Eikon: ID:nGNX8jyrnZ
Further company coverage: STRO.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates